Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Julphar
Teva
McKinsey
Fish and Richardson
Federal Trade Commission

Generated: March 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DICLOFENAC SODIUM

« Back to Dashboard

Clinical Trials for Diclofenac Sodium

Trial ID Title Status Sponsor Phase Summary
NCT00092378 A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 This purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following bunionectomy surgery.
NCT00092703 Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.
NCT00092742 Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) Completed Merck Sharp & Dohme Corp. Phase 3 The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.
NCT00140972 A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 4 A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
NCT00171626 Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis Completed Novartis Phase 3 This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.
NCT00171652 Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis Completed Novartis Phase 3 This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.
NCT00171665 Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis Completed Novartis Phase 3 This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Diclofenac Sodium

Condition Name

Condition Name for Diclofenac Sodium
Intervention Trials
Osteoarthritis 10
Pain 10
Healthy 5
Postoperative Pain 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Diclofenac Sodium
Intervention Trials
Osteoarthritis 19
Osteoarthritis, Knee 13
Pain, Postoperative 7
Sprains and Strains 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Diclofenac Sodium

Trials by Country

Trials by Country for Diclofenac Sodium
Location Trials
United States 185
India 20
Brazil 13
China 10
Egypt 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Diclofenac Sodium
Location Trials
Texas 14
Florida 13
California 10
Pennsylvania 8
Ohio 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Diclofenac Sodium

Clinical Trial Phase

Clinical Trial Phase for Diclofenac Sodium
Clinical Trial Phase Trials
Phase 4 24
Phase 3 40
Phase 2/Phase 3 4
[disabled in preview] 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Diclofenac Sodium
Clinical Trial Phase Trials
Completed 68
Recruiting 19
Unknown status 9
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Diclofenac Sodium

Sponsor Name

Sponsor Name for Diclofenac Sodium
Sponsor Trials
Novartis 12
Merck Sharp & Dohme Corp. 6
PPD 5
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Diclofenac Sodium
Sponsor Trials
Industry 69
Other 61
U.S. Fed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
Cantor Fitzgerald
QuintilesIMS
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.